By James Muonwa
THE University of Zimbabwe (UZ), which has been leading research and innovation on Zumbani (Lippia Javanica), is on the brink of putting three products made from the locally available medicinal herb on shop shelves.
Obert Jiri, a professor at the UZ research and innovation directorate told NewZimbabwe.com, Zumbani products that have proven medicinal properties to manage Covid-19 and other ailments, were in the process of being registered with the medicines regulator, Medicines Control Authority of Zimbabwe (MCAZ).
“Research has produced some things that are helpful, such as Zumbani ointment, capsules, and tea which we are producing at the university,” he said.
Share this article
Share this article
BEDMINSTER, N.J., May 4, 2021 /PRNewswire/ Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) a global specialty pharmaceutical company, recently named Ernesto Aycardi, M.D., to the position of Chief Development Officer on April 26, and is welcoming Eslie Dennis, M.D., MBChB, FCP(SA) in the role of Chief Medical Officer today. These appointments come at a pivotal time for the company, as the North America region aims to realize the full potential of its existing commercial portfolio and compounds being investigated in the pipeline. In particular, the company is working on plans to advance KW-6356, a selective antagonist of adenosine A2A receptors, and KHK4083, an Anti-OX40 Fully Human Antibody, and is also collaborating with partner MEI Pharma to complete the pivotal study and shape a broader development program for zandelisib, a selective PI3Kδ inhibitor.
CareFirst BlueCross BlueShield appointed Dr.
Tich Changamire as its new chief medical officer.
Changamire brings more than 20 years of medical and health plan experience, and provider-based healthcare leadership to his new role.
He will lead the organization’s efforts to achieve excellence in health care affordability, quality, and accessibility through innovative initiatives to improve the health of members and the communities we serve.
Changamire has an extensive and diverse background in the field of medicine. After serving as a Medical Officer in Zimbabwe early in his career and experiencing the HIV health crisis firsthand, Changamire began his career in public health to positively impact health at a systems level.
4/30/2021, 6 a.m. Dr. Tich Changamire has been ap- pointed the new Chief Medical Officer (CMO) for CareFirst BlueCross BlueShield. He will help accelerate the companyâs health equity capabilities strengthening affordability, quality, and access to care. Courtesy Photo/CareFirst
Baltimoreâ CareFirst BlueCross BlueShield (CareFirst) has appointed Dr. Tich Changamire as their new Chief Medical Officer.
Dr. Changamire brings more than 20 years of medical and health plan experience, and provider-based healthcare leadership to his new role.
He will lead the organizationâs efforts to achieve excellence in healthcare affordability, quality, and accessibility through innovative initiatives to improve the health of members and the communities we serve.
Zanu PF says amendment correcting flaws in Zimbabwe Constitution thezimbabwemail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thezimbabwemail.com Daily Mail and Mail on Sunday newspapers.